HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices.

DavidSlotwiner,MD, FHRS, FACC(Chair),Niraj Varma,MD,PhD, FRCP(Co-chair), JosephG.Akar,MD,PhD, George Annas, JD, MPH, Marianne Beardsall, MN/NP, CCDS, FHRS, Richard I. Fogel, MD, FHRS, Nestor O. Galizio, MD, Taya V. Glotzer, MD, FHRS, FACC, Robin A. Leahy, RN, BSN, CCDS, FHRS, Charles J. Love, MD, CCDS, FHRS, FACC, FAHA, Rhondalyn C. McLean, MD, Suneet Mittal, MD, FHRS, Loredana Morichelli, RN, MSN, Kristen K. Patton, MD, Merritt H. Raitt, MD, FHRS, Renato Pietro Ricci, MD, John Rickard, MD, MPH, Mark H. Schoenfeld, MD, CCDS, FHRS, FACC, FAHA, Gerald A. Serwer, MD, FHRS, FACC, Julie Shea, MS, RNCS, FHRS, CCDS, Paul Varosy, MD, FHRS, FACC, FAHA, Atul Verma, MD, FHRS, FRCPC, Cheuk-Man Yu, MD, FACC, FRCP, FRACP From the Hofstra School of Medicine, North Shore Long Island Jewish Health System, New Hyde Park, New York, Cleveland Clinic, Cleveland, Ohio, Yale University School of Medicine, New Haven, Connecticut, Boston University School of Public Health, Boston, Massachusetts, Southlake Regional Health Centre, Newmarket, Ontario, Canada, St. Vincent Medical Group, Indianapolis, Indiana, Favaloro Foundation University Hospital, Buenos Aires, Argentina, Hackensack University Medical Center, Hackensack, New Jersey, Sanger Heart & Vascular Institute, Carolinas HealthCare System, Charlotte, North Carolina, New York University Langone Medical Center, New York City, New York, University of Pennsylvania Health System, Philadelphia, Pennsylvania, The Arrhythmia Institute at Valley Hospital, New York, New York, Department of Cardiovascular Diseases, San Filippo Neri Hospital, Rome, Italy, University of Washington, Seattle, Washington, VA Portland Health Care System, Oregon Health & Science University, Knight Cardiovascular Institute, Portland, Oregon, Johns Hopkins University, Baltimore, Maryland, Yale University School of Medicine, Yale-New Haven Hospital Saint Raphael Campus, New Haven, Connecticut, University of Michigan Congenital Heart Center, University of Michigan Health Center, Ann Arbor, Michigan, Brigham and Women’s Hospital, Boston, Massachusetts, Veterans Affairs Eastern Colorado Health Care System, University of Colorado, Denver, Colorado, and Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China.

[1]  S. Markowitz,et al.  Newly Detected Atrial Fibrillation Following Dual Chamber Pacemaker Implantation , 2006, Journal of cardiovascular electrophysiology.

[2]  A. Schirdewan,et al.  Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  Cristina Masella,et al.  CONSORT-EHEALTH Checklist V1.6.2 Report , 2013 .

[4]  Renato Pietro Ricci,et al.  Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[5]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[6]  R. Ricci,et al.  Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up , 2014, Journal of Interventional Cardiac Electrophysiology.

[7]  P. Heidenreich,et al.  Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up: The ALTITUDE Survival Study , 2010, Circulation.

[8]  L. Tavazzi,et al.  Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. , 2011, European heart journal.

[9]  Wojciech Zareba,et al.  ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  Gillian D Sanders,et al.  Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial , 2010, Journal of cardiovascular electrophysiology.

[11]  A. Chirico,et al.  Economic impact of remote monitoring on ordinary follow-up of implantable cardioverter defibrillators as compared with conventional in-hospital visits. A single-center prospective and randomized study , 2013, Journal of Interventional Cardiac Electrophysiology.

[12]  Implantable Cardioverter-Defibrillators and Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy , 2009 .

[13]  Michel Chauvin,et al.  Potential Cost Savings by Telemedicine‐Assisted Long‐Term Care of Implantable Cardioverter Defibrillator Recipients , 2005, Pacing and clinical electrophysiology : PACE.

[14]  J. Clémenty,et al.  Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  J. Triedman,et al.  Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. , 2008, Journal of the American College of Cardiology.

[16]  S. Priori,et al.  HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. , 2008, Heart rhythm.

[17]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[18]  N. Varma,et al.  Prevalence of Cancelled Shock Therapy and Relationship to Shock Delivery in Recipients of Implantable Cardioverter‐Defibrillators Assessed by Remote Monitoring , 2009, Pacing and clinical electrophysiology : PACE.

[19]  H. Burri,et al.  Cost–consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[20]  B. Stambler,et al.  Same-day discovery of implantable cardioverter defibrillator dysfunction in the TRUST remote monitoring trial: influence of contrasting messaging systems , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  S. Sack,et al.  Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure–cardiac resynchronization therapy population , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[22]  M. Santini,et al.  Impact of in-clinic follow-up visits in patients with implantable cardioverter defibrillators: demographic and socioeconomic analysis of the TARIFF study population , 2013, Journal of Interventional Cardiac Electrophysiology.

[23]  J. Burkhardt,et al.  Remote Interrogation and Monitoring of Implantable Cardioverter Defibrillators , 2004, Journal of Interventional Cardiac Electrophysiology.

[24]  Laura G. Qualls,et al.  Follow-up of Patients With New Cardiovascular Implantable Electronic Devices: Are Experts’ Recommendations Implemented in Routine Clinical Practice? , 2013, Circulation. Arrhythmia and electrophysiology.

[25]  Renato Pietro Ricci,et al.  Long-term patient acceptance of and satisfaction with implanted device remote monitoring. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  P. Heidenreich,et al.  Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. , 2011, Heart rhythm.

[27]  J. Halperin,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[28]  Philippe Mabo,et al.  A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial) , 2011, European heart journal.

[29]  H. Burri Remote follow-up and continuous remote monitoring, distinguished. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[30]  Wataru Shimizu,et al.  Brugada syndrome: report of the second consensus conference. , 2005, Heart rhythm.

[31]  Christian Butter,et al.  Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. , 2007, European heart journal.

[32]  F. Oliva,et al.  Monitoring Intrathoracic Impedance with an Implantable Defibrillator Reduces Hospitalizations in Patients with Heart Failure , 2009, Pacing and clinical electrophysiology : PACE.

[33]  T. Bunch,et al.  Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality. , 2009, Heart rhythm.

[34]  S. Winters,et al.  The role of the Heart Rhythm Society in integrating the healthcare enterprise. , 2007, Heart rhythm.

[35]  D. Lacroix,et al.  Decreased Delivery of Inappropriate Shocks Achieved by Remote Monitoring of ICD: A Substudy of the ECOST Trial , 2014, Journal of cardiovascular electrophysiology.

[36]  D. Weiss,et al.  Remote Monitoring of Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.

[37]  P. Brugada,et al.  Role of home monitoring in children with implantable cardioverter defibrillators for Brugada syndrome. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[38]  J. Brugada,et al.  ECG phenomenon of idiopathic and paradoxical short QT intervals. , 2002, Cardiac electrophysiology review.

[39]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[40]  Frank Beckers,et al.  Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.

[41]  G. Boriani,et al.  Ventricular rate monitoring as a tool to predict and prevent atrial fibrillation-related inappropriate shocks in heart failure patients treated with cardiac resynchronisation therapy defibrillators , 2014, Heart.

[42]  D. Theuns,et al.  Home monitoring in ICD therapy: future perspectives. , 2003, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[43]  N. Varma Remote Monitoring for Advisories: Automatic Early Detection of Silent Lead Failure , 2009, Pacing and clinical electrophysiology : PACE.

[44]  Cristina Masella,et al.  Remote Monitoring of CRT‐ICD: The Multicenter Italian CareLink Evaluation—Ease of Use, Acceptance, and Organizational Implications , 2008, Pacing and clinical electrophysiology : PACE.

[45]  A. Capucci,et al.  Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events , 2014, Circulation.

[46]  G. Hindricks,et al.  Quarterly vs. yearly clinical follow-up of remotely monitored recipients of prophylactic implantable cardioverter-defibrillators: results of the REFORM trial , 2013, European heart journal.

[47]  Dominique Lacroix,et al.  Costs of remote monitoring vs. ambulatory follow-ups of implanted cardioverter defibrillators in the randomized ECOST study , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[48]  Niraj Varma,et al.  Remote monitoring of cardiovascular devices: a time and activity analysis. , 2012, Heart rhythm.

[49]  Hongyan Qiao,et al.  Clinical benefits of remote versus transtelephonic monitoring of implanted pacemakers. , 2009, Journal of the American College of Cardiology.

[50]  L. Jordaens,et al.  Who Are the Long-QT Syndrome Patients Who Receive an Implantable Cardioverter-Defibrillator and What Happens to Them?: Data From the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry , 2010, Circulation.

[51]  M. Linnaluoto,et al.  Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[52]  M. Orlov,et al.  Asymptomatic Atrial Fibrillation in Pacemaker Recipients: Incidence, Progression, and Determinants Based on the Atrial High Rate Trial , 2007, Pacing and clinical electrophysiology : PACE.

[53]  Luca Segreti,et al.  Superior vena cava defibrillator coils make transvenous lead extraction more challenging and riskier. , 2013, Journal of the American College of Cardiology.

[54]  A. Curnis,et al.  Manpower and Outpatient Clinic Workload for Remote Monitoring of Patients with Cardiac Implantable Electronic Devices: Data from the HomeGuide Registry , 2014, Journal of cardiovascular electrophysiology.

[55]  R. Schweikert,et al.  Efficacy and Safety of Automatic Remote Monitoring for Implantable Cardioverter-Defibrillator Follow-Up: The Lumos-T Safely Reduces Routine Office Device Follow-Up (TRUST) Trial , 2010, Circulation.

[56]  Massimo Santini,et al.  Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. , 2005, Journal of the American College of Cardiology.

[57]  R. Schweikert,et al.  Automatic Remote Monitoring of Implantable Cardioverter-Defibrillator Lead and Generator Performance: The Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) Trial , 2010, Circulation. Arrhythmia and electrophysiology.

[58]  Sana M. Al-Khatib,et al.  Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[59]  Finn Kensing,et al.  Patient satisfaction and suggestions for improvement of remote ICD monitoring , 2012, Journal of Interventional Cardiac Electrophysiology.

[60]  Maurizio Marzegalli,et al.  Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators: The Evolution of Management Strategies of Heart Failure Patients With Implantable Defibrillators (EVOLVO) Study , 2012, Circulation.

[61]  M. Borggrefe,et al.  Intrathoracic Impedance Monitoring, Audible Patient Alerts, and Outcome in Patients With Heart Failure , 2011, Circulation.

[62]  S. Chun,et al.  Detection of Atrial Fibrillation by Implanted Devices with Wireless Data Transmission Capability , 2005, Pacing and clinical electrophysiology : PACE.

[63]  P. Heidenreich,et al.  Real World Evaluation of Dual‐Zone ICD and CRT‐D Programming Compared to Single‐Zone Programming: The ALTITUDE REDUCES Study , 2011, Journal of cardiovascular electrophysiology.

[64]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[65]  A. Lazarus Remote, Wireless, Ambulatory Monitoring of Implantable Pacemakers, Cardioverter Defibrillators, and Cardiac Resynchronization Therapy Systems: Analysis of a Worldwide Database , 2007, Pacing and clinical electrophysiology : PACE.

[66]  A. Capucci,et al.  Presence and Duration of Atrial Fibrillation Detected by Continuous Monitoring: Crucial Implications for the Risk of Thromboembolic Events , 2009, Journal of cardiovascular electrophysiology.

[67]  Dongfeng Qi,et al.  The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.

[68]  P. Neužil,et al.  Early automatic remote detection of combined lead insulation defect and ICD damage. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[69]  D. Hettrick,et al.  Implantable CRT device diagnostics identify patients with increased risk for heart failure hospitalization , 2008, Journal of Interventional Cardiac Electrophysiology.

[70]  G. Lamas,et al.  Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) , 2003, Circulation.

[71]  Johnson Francis,et al.  Remote Monitoring of Implantable Cardioverter Defibrillator , 2006, Indian pacing and electrophysiology journal.

[72]  G. Hindricks,et al.  Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial , 2014, The Lancet.

[73]  Silvia G Priori,et al.  HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[74]  Dominique Lacroix,et al.  A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial , 2012, European heart journal.

[75]  Jeffrey L. Anderson,et al.  The Evolution and Future of ACC/AHA Clinical Practice Guidelines: A 30-Year Journey A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Circulation.

[76]  J. Piccini,et al.  The Relationship Between Level of Adherence to Automatic Wireless Remote Monitoring and Survival in Pacemaker and Defibrillator Patients. , 2015, Journal of the American College of Cardiology.

[77]  D. Hettrick,et al.  Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: clinical utility of implanted device monitoring without a patient alert. , 2009, Journal of cardiac failure.

[78]  Niraj Varma,et al.  Superiority of automatic remote monitoring compared with in-person evaluation for scheduled ICD follow-up in the TRUST trial - testing execution of the recommendations , 2014, European heart journal.

[79]  Haran Burri,et al.  The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention With Remote Monitoring , 2013, Journal of medical Internet research.

[80]  Renato Pietro Ricci,et al.  Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[81]  M. Wright,et al.  Remote implantable cardioverter defibrillator monitoring in a Brugada syndrome population. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[82]  A. Boyle,et al.  The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. , 2011, Journal of the American College of Cardiology.

[83]  James P. Titus,et al.  Security and Privacy , 1967, 2022 IEEE Future Networks World Forum (FNWF).

[84]  R. Ricci,et al.  Effect of daily remote monitoring on pacemaker longevity: a retrospective analysis. , 2015, Heart rhythm.

[85]  Kevin Fu,et al.  Pacemakers and Implantable Cardiac Defibrillators: Software Radio Attacks and Zero-Power Defenses , 2008, 2008 IEEE Symposium on Security and Privacy (sp 2008).

[86]  Domenico Catanzariti,et al.  Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: A case-control study , 2007, Journal of Interventional Cardiac Electrophysiology.

[87]  H. Heidbuchel,et al.  EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring , 2014, European heart journal.

[88]  Niraj Varma,et al.  Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study. , 2007, American heart journal.

[89]  G. Lip,et al.  Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. , 2015, European heart journal.